Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Nuvalent Inc (NUVL) – Nuvalent Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Nuvalent (NUVL) trades at $123.43, up 0.06% on the day, following the announcement of its acquisition by GSK for $124 per share in an all-cash deal valued at $10.6 billion. The stock is trading near the acquisition price, with technical indicators showing a bullish trend. Financially, the company remains in a pre-revenue stage with negative profitability metrics, including a -41.19% ROE and -$425.38M net income for 2025, but the acquisition provides a clear exit for shareholders.
The investment outlook is dominated by the pending acquisition, offering a near-term gain to the $124 buyout price. Primary risks include potential delays or regulatory hurdles in the deal closure, while the fundamental lack of profitability is mitigated by the strategic value GSK places on Nuvalent's oncology pipeline. Analyst consensus is positive, with a $131.22 price target reflecting confidence in the transaction's completion.
Read full analysis

Key Stats

  • Market Cap
    $9.76B
  • Sector
    Technology
  • 3M Drawdown
    -19.84%
  • Enterprise Value
    $8.48B
  • Dividend Yield
    -
  • Typical Hold Time
    6 days
$123.48
52W Low: $72.16
07 Aug 2025
52W High: $123.48
23 Jun 2026

Nuvalent Inc (NUVL) is currently valued at a market capitalization of $9.76B, with an enterprise value of $8.48B. Over the past 52 weeks, Nuvalent Inc has traded between a low of $72.16 and a high of $123.48, highlighting its annual price range. Over the past three months, Nuvalent Inc has recorded a drawdown of -19.84%, reflecting recent price volatility. On average, investors hold Nuvalent Inc for approximately 6 days, indicating typical investor behavior on the platform.

About Nuvalent Inc

Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.


People also bought


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $9.76B
  • Sector
    Technology
  • 3M Drawdown
    -19.84%
  • Enterprise Value
    $8.48B
  • Dividend Yield
    -
  • Typical Hold Time
    6 days
$123.48
52W Low: $72.16
07 Aug 2025
52W High: $123.48
23 Jun 2026

Nuvalent Inc (NUVL) is currently valued at a market capitalization of $9.76B, with an enterprise value of $8.48B. Over the past 52 weeks, Nuvalent Inc has traded between a low of $72.16 and a high of $123.48, highlighting its annual price range. Over the past three months, Nuvalent Inc has recorded a drawdown of -19.84%, reflecting recent price volatility. On average, investors hold Nuvalent Inc for approximately 6 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!